abstract |
IL-12 antibodies that include the antigen binding portions thereof are described herein. The methods for the isolation and purification of anti-lL-12 antibodies from a sample matrix are presented. These anti-IL-12 antibodies can be used in a clinical context as well as in research and development. Pharmaceutical compositions comprising the isolated anti-IL-12 antibodies are also described. |